Traws Pharma's total assets for Q2 2024 were $18.69M, an increase of 2.83% from the previous quarter. TRAW total liabilities were $12.59M for the fiscal quarter, a 3.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.